OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy
Bo Hou, Ting Chen, He Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Regulatory mechanisms of PD-1/PD-L1 in cancers
Xin Lin, Kuan Kang, Pan Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 42

Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
Fangfang Liu, Jingyu Chen, Kai Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12

Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer
Bi Lian, Xiaosong Chen, Kunwei Shen
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23

Recent advances and mechanisms of action of PD-L1 degraders as potential therapeutic agents
Feng Zhang, Ruiya Jiang, Shishi Sun, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116267-116267
Closed Access | Times Cited: 5

CD28 co-stimulation: novel insights and applications in cancer immunotherapy
Michael T. Lotze, Scott H. Olejniczak, Dimitris Skokos
Nature reviews. Immunology (2024) Vol. 24, Iss. 12, pp. 878-895
Closed Access | Times Cited: 4

The E3 ubiquitin ligases regulate inflammation in cardiovascular diseases
Xiaohong Chen, Jia Ma, Zhiwei Wang, et al.
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 167-174
Closed Access | Times Cited: 13

Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
Xin Zhang, Xuemei Wang, Lijian Hou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13

PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies
Maoyu Wang, Zhensheng Zhang, Zhizhou Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7

Long noncoding RNAs regulate intrauterine adhesion and cervical cancer development and progression
Xuemei Wang, Yu Gu, Leichao Zhang, et al.
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 221-226
Closed Access | Times Cited: 6

The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy
Xuemei Wang, Ying Zhang, Yao Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5

CDC20 promotes radioresistance of prostate cancer by activating Twist1 expression
Chuanlai Yang, Yuegang Ge, Yachen Zang, et al.
APOPTOSIS (2023) Vol. 28, Iss. 11-12, pp. 1584-1595
Closed Access | Times Cited: 5

A combination of cuproptosis and lncRNAs predicts the prognosis and tumor immune microenvironment in cervical cancer
Yitong Huang, Chenxiang Pan, Suni Wu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1

Demethylzeylasteral induces PD-L1 ubiquitin–proteasome degradation and promotes antitumor immunity via targeting USP22
Yanyan Zhang, Yun Huang, Dianping Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4312-4328
Open Access | Times Cited: 1

Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy
Angela Lauriola, Pierpaola Davalli, Gaetano Marverti, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 3009-3009
Open Access | Times Cited: 3

Ubiquitination-related biomarkers in metastatic melanoma patients and their roles in tumor microenvironment
Zhang Li, Zhehao Shi, Fan Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2

E3 ubiquitin ligases in lung cancer: Emerging insights and therapeutic opportunities
Bhaskar Basu, Satadeepa Kal, Subhajit Karmakar, et al.
Life Sciences (2023) Vol. 336, pp. 122333-122333
Closed Access | Times Cited: 2

Programmed Death Ligand 1 Regulatory Crosstalk with Ubiquitination and Deubiquitination: Implications in Cancer Immunotherapy
Soon-Bin Kim, Soonjae Hwang, Ji-Young Cha, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2939-2939
Open Access

Investigating BRCA Stem Cell Contributions to Lymph Node Metastasis
Hua Shao, Hanlu Tang, Huiying Lin, et al.
(2024)
Closed Access

Unraveling role of ubiquitination in drug resistance of gynecological cancer
Yu Li
American Journal of Cancer Research (2024) Vol. 14, Iss. 5, pp. 2523-2537
Open Access

Decoding the Role of O-GlcNAcylation in Hepatocellular Carcinoma
Xinyu Zhou, Sirui Hang, Qingqing Wang, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 908-908
Open Access

Role of UFMylation in tumorigenesis and cancer immunotherapy
Lijuan Ding, Xin Jiang, Te Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

O-GlcNAcylation in ovarian tumorigenesis and its therapeutic implications
Lu Xia, Jie Mei, Min Huang, et al.
Translational Oncology (2024) Vol. 51, pp. 102220-102220
Closed Access

Page 1 - Next Page

Scroll to top